Researchers developed a multivariable model to predict clinically relevant posthepatectomy liver failure grade B and C, grade C, and 90-day mortality prediction.
Risk Adjusted Net Present Value: What is the current valuation of Catalyst Pharmaceuticals’s Vamorolone
The revenue for Vamorolone is expected to reach an annual total of $192 mn by 2032 in the US based off GlobalData’s Expiry Model. The
July 31, 2023